TCL Archive Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival April 25, 2014
TCL Archive Reviewers Report Progress In New Drug Prescreen System Development, Commend DTP December 15, 1989
TCL Archive Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL July 11, 2014